Menu
GeneBe

ADCYAP1

adenylate cyclase activating polypeptide 1, the group of Neuropeptides

Basic information

Region (hg38): 18:904870-912172

Links

ENSG00000141433NCBI:116OMIM:102980HGNC:241Uniprot:P18509AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the ADCYAP1 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the ADCYAP1 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
0
missense
9
clinvar
9
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
0
Total 0 0 9 0 0

Variants in ADCYAP1

This is a list of pathogenic ClinVar variants found in the ADCYAP1 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
18-905456-A-C not specified Uncertain significance (Jun 29, 2023)2608724
18-905472-C-T not specified Uncertain significance (Apr 11, 2023)2535802
18-907702-G-A not specified Uncertain significance (Mar 12, 2024)3082571
18-907724-C-G not specified Uncertain significance (Oct 03, 2022)2393601
18-907766-C-T not specified Uncertain significance (Dec 13, 2022)2334004
18-908299-C-T not specified Uncertain significance (Apr 14, 2022)2283040
18-908302-A-C not specified Uncertain significance (Oct 02, 2023)3082581
18-908306-T-C not specified Uncertain significance (Oct 25, 2022)2319129
18-908342-C-T not specified Uncertain significance (Jun 26, 2023)2589443

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
ADCYAP1protein_codingprotein_codingENST00000579794 47230
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.5240.461125726051257310.0000199
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-0.43311299.81.120.000004491086
Missense in Polyphen1631.0060.51602352
Synonymous-2.777046.11.520.00000217362
Loss of Function1.9616.300.1592.66e-784

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0001870.000185
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.000.00
European (Non-Finnish)0.000008830.00000879
Middle Eastern0.000.00
South Asian0.00003290.0000327
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Binding to its receptor activates G proteins and stimulates adenylate cyclase in pituitary cells. Promotes neuron projection development through the RAPGEF2/Rap1/B-Raf/ERK pathway. In chromaffin cells, induces long-lasting increase of intracellular calcium concentrations and neuroendocrine secretion (By similarity). Involved in the control of glucose homeostasis, induces insulin secretion by pancreatic beta cells (By similarity). {ECO:0000250|UniProtKB:O70176, ECO:0000250|UniProtKB:P13589, ECO:0000269|PubMed:11175907, ECO:0000269|PubMed:23800469}.;
Pathway
Renin secretion - Homo sapiens (human);Insulin secretion - Homo sapiens (human);Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways;Signaling by GPCR;Activation of TRKA receptors;Signal Transduction;NGF-independant TRKA activation;G alpha (s) signalling events;Glucagon-type ligand receptors;Class B/2 (Secretin family receptors);GPCR ligand binding;Signaling by NTRK1 (TRKA);Signaling by NTRKs;Signaling by Receptor Tyrosine Kinases;GPCR downstream signalling (Consensus)

Recessive Scores

pRec
0.311

Intolerance Scores

loftool
0.484
rvis_EVS
-0.19
rvis_percentile_EVS
39.68

Haploinsufficiency Scores

pHI
0.247
hipred
N
hipred_score
0.441
ghis
0.395

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.574

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Adcyap1
Phenotype
muscle phenotype; homeostasis/metabolism phenotype; cellular phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); hematopoietic system phenotype; growth/size/body region phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); immune system phenotype; liver/biliary system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan);

Zebrafish Information Network

Gene name
adcyap1b
Affected structure
forebrain
Phenotype tag
abnormal
Phenotype quality
deformed

Gene ontology

Biological process
G protein-coupled receptor signaling pathway;adenylate cyclase-activating G protein-coupled receptor signaling pathway;activation of adenylate cyclase activity;positive regulation of cytosolic calcium ion concentration;neuropeptide signaling pathway;cell-cell signaling;female pregnancy;regulation of G protein-coupled receptor signaling pathway;regulation of signaling receptor activity;cAMP-mediated signaling;insulin secretion;neuron projection development;regulation of protein localization;positive regulation of GTPase activity;positive regulation of protein kinase activity;positive regulation of transcription by RNA polymerase II;positive regulation of growth hormone secretion;positive regulation of ERK1 and ERK2 cascade;positive regulation of chemokine (C-C motif) ligand 5 production;positive regulation of cold-induced thermogenesis
Cellular component
extracellular region;neuron projection;perikaryon
Molecular function
signaling receptor binding;neuropeptide hormone activity;protein binding;pituitary adenylate cyclase activating polypeptide activity;peptide hormone receptor binding